Home » Stocks » ATR

AptarGroup, Inc. (ATR)

Stock Price: $148.08 USD 0.88 (0.60%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 9.78B
Revenue (ttm) 2.93B
Net Income (ttm) 214.04M
Shares Out 64.72M
EPS (ttm) 3.21
PE Ratio 46.13
Forward PE 35.84
Dividend $1.44
Dividend Yield 0.97%
Trading Day April 16
Last Price $148.08
Previous Close $147.20
Change ($) 0.88
Change (%) 0.60%
Day's Open 149.14
Day's Range 147.57 - 149.59
Day's Volume 322,614
52-Week Range 98.26 - 149.59

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, April 6, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) diso...

Other stocks mentioned: SEEL
1 week ago - PRNewsWire

AMCR vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: AMCR
2 weeks ago - Zacks Investment Research

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

4 weeks ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has again been named one of Barron's 100 M...

1 month ago - Business Wire

AMCR vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: AMCR
1 month ago - Zacks Investment Research

AptarGroup's (ATR) fourth-quarter results improve on solid growth in the Pharma segment and the personal care and home care markets.

1 month ago - Zacks Investment Research

AptarGroup (ATR) delivered earnings and revenue surprises of 2.22% and 1.80%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of AptarGroup (NYSE:ATR) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 15.00% over the past year to $0.92, which beat the esti...

2 months ago - Benzinga

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2020 and highlighted the resiliency of the Company's business model throughout the C...

2 months ago - Business Wire

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has partnered with CARE®, a 501(c) organi...

2 months ago - Business Wire

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ technology...

2 months ago - Business Wire

GPK vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: GPK
2 months ago - Zacks Investment Research

Alphabet's growth and news of Amazon founder and CEO, Jeff Bezos, stepping down are moving the markets. With so much happening, our artificial intelligence has found you today's best Top Buys.

Other stocks mentioned: AVNT, NX, PLXS
2 months ago - Forbes

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend ...

3 months ago - Business Wire

Demand for AptarGroup's (ATR) pharmaceutical products and sanitizers, liquid soaps and disinfectants makes the stock a prudent investment pick.

3 months ago - Zacks Investment Research

SON vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: SON
3 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently published new policies aroun...

3 months ago - Business Wire

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times of quarterl...

3 months ago - Business Wire

Triggered by the pandemic, increasing demand for pharmaceutical products and sanitizers, liquid soaps and disinfectants featuring AptarGroup's (ATR) solutions is driving its shares.

4 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently been recognized with Prime s...

4 months ago - Business Wire

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been recognized for its leadership in...

4 months ago - Business Wire

AptarGroup (ATR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

4 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of “America's Most Res...

4 months ago - Business Wire

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of the “Most Responsible...

4 months ago - Business Wire

Pandemic-induced demand for pharmaceutical products is likely to drive AptarGroup's (ATR) Pharma segment, while demand in personal care market and home care market will aid the Beauty + Home segment.

4 months ago - Zacks Investment Research

Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.

4 months ago - Zacks Investment Research

AptarGroup's (ATR) top and bottom lines improve on solid growth in the Pharma segment as well as in the food, personal care and home care markets during the July-September period.

5 months ago - Zacks Investment Research

PKG vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: PKG
5 months ago - Zacks Investment Research

AptarGroup's (ATR) CEO Stephan Tanda on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

AptarGroup (ATR) delivered earnings and revenue surprises of 19.05% and 7.51%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) today reported third quarter results for 2020 and provided an update related to COVID-19 including the Company's continued supply of esse...

5 months ago - Business Wire

AptarGroup's (ATR) third-quarter 2020 results are likely to reflect higher demand for pharmaceutical products amid the COVID-19 pandemic. However, weak beauty products sales will negate these gains.

5 months ago - Zacks Investment Research

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

SON vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: SON
6 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend ...

6 months ago - Business Wire

AptarGroup (ATR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

6 months ago - Zacks Investment Research

BERY vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: BERY
6 months ago - Zacks Investment Research

How demand for sanitizers created a dispenser and packaging shortage

YouTube video

CNBC's Kelly Evans discusses how the sanitizer boom has impacted dispenser and packaging manufacturing with Stephan Tandy, CEO of Aptar Group.

7 months ago - CNBC Television

The company has handled COVID-19 fairly well and has made it through the worst of it with minimal damage.

7 months ago - Seeking Alpha

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

7 months ago - Zacks Investment Research

AptarGroup (ATR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

7 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc.

7 months ago - Business Wire

Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.

8 months ago - Zacks Investment Research

BERY vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: BERY
8 months ago - Zacks Investment Research

AptarGroup (ATR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

8 months ago - Zacks Investment Research

AptarGroup's (ATR) core sales growth in the Pharma segment in Q2 is partly offset by decline in core sales in other segments due to the coronavirus pandemic.

8 months ago - Zacks Investment Research

AptarGroup Inc. (ATR) CEO Stephan Tanda on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

AptarGroup (ATR) delivered earnings and revenue surprises of 17.65% and 6.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc.

8 months ago - Business Wire

AptarGroup (ATR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

8 months ago - Zacks Investment Research

About ATR

AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary pack... [Read more...]

Industry
Packaging & Containers
IPO Date
Apr 21, 1993
CEO
Stephan Tanda
Employees
13,000
Stock Exchange
NYSE
Ticker Symbol
ATR
Full Company Profile

Financial Performance

In 2020, AptarGroup's revenue was $2.93 billion, an increase of 2.43% compared to the previous year's $2.86 billion. Earnings were $214.04 million, a decrease of -11.63%.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for AptarGroup stock is "Buy." The 12-month stock price forecast is 151.14, which is an increase of 2.07% from the latest price.

Price Target
$151.14
(2.07% upside)
Analyst Consensus: Buy